EUVIMEDEUVIMED entdecken
Crossref

Empiric Antibiotic Therapy and Neurodevelopment Outcome of Very Low Birth Weight Infants

Marina P Menegolla iD, Rita C Silveira iD, Antônio R H Görgen iD, Fernanda E Gandolfi iD, Carolina Panceri iD, Renato S Procianoy iD

Neuropediatrics · 01.10.2025 · 56 (05) · 320-327

DOI: 10.1055/a-2561-8208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropediatrics, erschienen am 01.10.2025. Verfasst von Marina P Menegolla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Newborn Section, Child Health and Adolescent Medicine Graduate Program, Department of Pediatrics, Universidade Federal do Rio Grande do Sul, Hospital…. Hauptthemen laut MEDLINE: Infant, Very Low Birth Weight, Anti-Bacterial Agents, Neurodevelopmental Disorders, Sepsis. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To determine the effects of empiric antibiotic therapy within the first 72 hours after birth, in cases of suspected early-onset sepsis without positive blood cultures, on the neurodevelopment of VLBW infants. Cohort study conducted from January 2014 to December 2021, included neonates from 24 to 32 weeks' gestation. They were categorized based on receiving early antibiotics. Outcomes measured included neonatal morbidities and scores on the Bayley Scales of Infant Development, Third Edition (BSID-III), at 12 to 36 months corrected age. Of 261 VLBW infants 52.9% (n = 138) received empiric antibiotics within the first 72 hours, while 47.1% (n = 123) did not. Multivariate analysis revealed no association between early antibiotics and neurodevelopmental delay. Severe intraventricular hemorrhage independently correlated with delays, while late-onset sepsis and bronchopulmonary dysplasia contributed to specific motor and cognitive delays. Propensity score matching (PSM) was conducted using various models that included gestational age, late-onset sepsis, severe intraventricular hemorrhage, bronchopulmonary dysplasia, and clinical chorioamnionitis. However, antibiotic use was not independently associated with an increased risk of developmental delay in the applied models. Although the use of antibiotics did not emerge as an independent factor contributing to developmental delay, VLBW infants who received antibiotics had more morbidities during their NICU stay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant, Very Low Birth WeightAnti-Bacterial AgentsNeurodevelopmental DisordersSepsisDevelopmental DisabilitiesChild DevelopmentHumansInfant, NewbornFemaleMaleInfantCohort StudiesChild, PreschoolBronchopulmonary DysplasiaCerebral Intraventricular Hemorrhage

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Newborn Section, Child Health and Adolescent Medicine Graduate Program, Department of Pediatrics, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.

ORCID-Profile: Marina P Menegolla, Rita C Silveira, Antônio R H Görgen, Fernanda E Gandolfi, Carolina Panceri, Renato S Procianoy

Zitieren

APA

Menegolla, M. P., Silveira, R. C., Görgen, A. R. H., Gandolfi, F. E., Panceri, C., & Procianoy, R. S. (2025). Empiric Antibiotic Therapy and Neurodevelopment Outcome of Very Low Birth Weight Infants. Neuropediatrics, 56(05), 320-327. https://doi.org/10.1055/a-2561-8208

Vancouver

Menegolla MP, Silveira RC, Görgen ARH, Gandolfi FE, Panceri C, Procianoy RS. Empiric Antibiotic Therapy and Neurodevelopment Outcome of Very Low Birth Weight Infants. Neuropediatrics. 2025;56(05):320-327. doi:10.1055/a-2561-8208

BibTeX
@article{Menegolla2025,
  author = {Menegolla, Marina P and Silveira, Rita C and Görgen, Antônio R H and Gandolfi, Fernanda E and Panceri, Carolina and Procianoy, Renato S},
  title = {Empiric Antibiotic Therapy and Neurodevelopment Outcome of Very Low Birth Weight Infants},
  journal = {Neuropediatrics},
  year = {2025},
  volume = {56},
  number = {05},
  pages = {320--327},
  doi = {10.1055/a-2561-8208}
}
Kostenlos starten →